Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study of 177Lu-FAP-2286 in Advanced Solid TumorsSolid TumorRecruitingPhase 1 / Phase 22026-07-24NCT04939610

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Novartis Pharmaceuticals432

35 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
City of HopeDuarteUnited States238
Columbia University Medical centerNew YorkUnited States224
Fred Hutchinson Cancer CenterSeattleUnited States5
Hoag Hospital IrvineIrvineUnited States7
Karmanos Cancer InstituteDetroitUnited States153
London Health Sciences CentreTorontoCanada1
Mayo ClinicRochesterUnited States664
Mayo ClinicJacksonvilleUnited States122
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
Novartis Investigating SiteMadridSpain1
Novartis Investigating SiteMadridSpain1
Novartis Investigating SiteBadalonaSpain1
Novartis Investigating SiteReggio EmiliaItaly1
Novartis Investigating SiteMarseilleFrance1
Novartis Investigating SiteMadridSpain1
Novartis Investigating SiteLondonCanada1
Novartis Investigating SiteMilanItaly1
Novartis Investigator SiteMontpellierFrance1
Novartis Investigator SiteBordeauxFrance1
Novartis Investigator SiteMurdochAustralia1
Novartis Investigator SiteVandœuvre-lès-NancyFrance1
Novartis Investigator SiteClermont-FerrandFrance1
Novartis Investigator SiteNaplesItaly1
Oregon Health and Science UniversityPortlandUnited States9
Saint Louis University HospitalSt LouisUnited States1